Full text
PDFPage 1339

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boton R., Gaviria M., Batlle D. C. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis. 1987 Nov;10(5):329–345. doi: 10.1016/s0272-6386(87)80098-7. [DOI] [PubMed] [Google Scholar]
- Carmichael J., Shankel S. W. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med. 1985 Jun;78(6 Pt 1):992–1000. doi: 10.1016/0002-9343(85)90223-2. [DOI] [PubMed] [Google Scholar]
- Garella S., Matarese R. A. Renal effects of prostaglandins and clinical adverse effects of nonsteroidal anti-inflammatory agents. Medicine (Baltimore) 1984 May;63(3):165–181. doi: 10.1097/00005792-198405000-00003. [DOI] [PubMed] [Google Scholar]
- Kincaid-Smith P. Effects of non-narcotic analgesics on the kidney. Drugs. 1986;32 (Suppl 4):109–128. doi: 10.2165/00003495-198600324-00009. [DOI] [PubMed] [Google Scholar]
- Robertson C. E., Ford M. J., Van Someren V., Dlugolecka M., Prescott L. F. Mefenamic acid nephropathy. Lancet. 1980 Aug 2;2(8188):232–233. doi: 10.1016/s0140-6736(80)90122-1. [DOI] [PubMed] [Google Scholar]
- Scharschmidt L., Simonson M., Dunn M. J. Glomerular prostaglandins, angiotensin II, and nonsteroidal anti-inflammatory drugs. Am J Med. 1986 Aug 25;81(2B):30–42. doi: 10.1016/0002-9343(86)90906-x. [DOI] [PubMed] [Google Scholar]
- Shelley R. K. Lithium toxicity and mefenamic acid. A possible interaction and the role of prostaglandin inhibition. Br J Psychiatry. 1987 Dec;151:847–848. doi: 10.1192/bjp.151.6.847. [DOI] [PubMed] [Google Scholar]
- Unsworth J., Sturman S., Lunec J., Blake D. R. Renal impairment associated with non-steroidal anti-inflammatory drugs. Ann Rheum Dis. 1987 Mar;46(3):233–236. doi: 10.1136/ard.46.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
